Navigation Links
Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting

" "believe," "estimate," "predict," "potential" or "continue," the negative of these terms and other comparable terminology. These statements are not historical facts but instead represent the Company's belief regarding future results, many of which, by their nature, are inherently uncertain and outside the Company's control. It is possible that actual results may differ, possibly materially, from those anticipated in these forward-looking statements. For a discussion of some of the risks and important factors that could affect future results, see the discussion in our Form 20-F for the year ended December 31, 2005, under the caption "Risk Factors."

Contact

Company Contact:
Gentium, S.p.A.
Gary G. Gemignani, Chief Financial Officer, 212-332-1666
ggemignani@gentium.com
or
Investor Relations Contacts:
U.S.:
Lippert/Heilshorn & Associates
Anne Marie Fields, 212-838-3777
afields@lhai.com
or
Bruce Voss, 310-691-7100
or
Italy:
Burson-Marsteller
Luca Ricci Maccarini, +39 02.721431
luca_maccarini@it.bm.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Gentiums Defibrotide Seen as Active in Multiple Myeloma
2. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
7. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
8. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress

Post Your Comments:
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswir...aq: ALXA ) announced today that its corporate pre...ual Piper Jaffray Health Care Conference on Wednes...The presentation will be webcast from The New York... Thomas B. King, Alexza President and CEO. ,,...
(Date:11/19/2009)..., , ABBOTT PARK, Ill., Nov. 19 /PRNewswire-F...ott (NYSE: ABT ) as one of its Most Admired Corp... The Deal honored Abbott as its Most Admired Dea...rategic use of acquisitions and divestitures since...has reshaped its business portfolio with a focus o...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 As t...nning noses is here. Here,s more on preparing your...l-Janssen Pharmaceuticals Inc. at: ,, http:/...RfCsbxc9R2VXAOIF ,, Medialink is a division ...ess video, audio, text, graphics and photos at h...
Breaking Medicine Technology:Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Ontario Institute for Cancer Research Validates NEBNext 28TM 29 DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Se 14283 1Ontario Institute for Cancer Research Validates NEBNext 28TM 29 DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Se 14283 2Leading Medical Device Provider Chooses TrackWise 28R 29 Software to Optimize Customer Complaint Handling 5074 1Leading Medical Device Provider Chooses TrackWise 28R 29 Software to Optimize Customer Complaint Handling 5074 2Leading Medical Device Provider Chooses TrackWise 28R 29 Software to Optimize Customer Complaint Handling 5074 3Caraco Pharmaceutical Laboratories Ltd Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations 5070 1Caraco Pharmaceutical Laboratories Ltd Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations 5070 2
...thcare,Foundation (AHF) today announced that it is...edicine, U.S. Prior to assuming his new role as,Ch...r of Medicine, Regional,Medical Director of Wester...sociate Director of Research and the Medical Direc...alley and Antelope Valley Healthcare,Centers. Dr. ...
...at and When Data from a six-month study of ramelt...ep07: The 5th World Congress of the World Federati...to be held in Cairns, Australia,September 2-6, 200...elteon,was effective in reducing time to fall asle...tients with chronic insomnia. A total of 451 pati...
Other Medicine Technology:AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S. 2New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 2New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 3
(Date:11/20/2009)...wire-FirstCall/ -- Rates of infection by the 2009 ...er, but the pandemic flu virus continues to be a p...uding the elderly, according to a new report by Qu...orld,s leading provider of diagnostic testing, inf...uest Diagnostics Health Trends(TM) Report "Testing...
(Date:11/20/2009)...-FirstCall/ -- Centene Corporation (NYSE: CNC ... of America Merrill Lynch 2009 Credit Conference, ... Hotel Times Square in New York City. ,, Centen.... Eastern Time. Investors and other interested par... presentation at: http://www.veracast.com/webcast...
(Date:11/20/2009)...ewswire-USNewswire/ -- Samuel Gladding is no Scroo...ns to be "happy" during the holidays. As a license...y counseling and chair of the Department of Counse...arch shows that it is the pressure to be happy tha...g the holidays. ,, That,s why he,s challenging ...
(Date:11/20/2009)...e-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIRI )...adio Reports: What Every Women Needs to Know Abou...an journalist Perri Peltz. ,, (Logo: http://w... ,, Doctor Radio Reports: What Every Woman N... 21 live at 10:00 am ET on Doctor Radio , SIRIUS ...
(Date:11/20/2009)... used for embalming in the funeral industry were a...loid leukemia, according to a new study published ... Cancer Institute . , Previous studies have show...ancies and brain cancer in anatomists, pathologist...ave worked with formaldehyde. , For this study...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
...igh School One of the 25 Healthiest Schools in the...ERDALE, Fla., Dec. 11 The ,got milk?(R), Milk,Mus...School Nutrition,Association and the President,s C...ation. The recognition is a result of,a nationwide...
... Amedica Corporation, an,orthopedic implants compa..., announced today that the U.S. Food and Drug Admi...clearance for Amedica,s Valeo(TM),ceramic VBR spin...mbar spine.,The Valeo VBR incorporates Amedica,s n...
...e red meat and processed meat you eat, the higher ...ews) -- A quarter-pound hamburger or a small pork ...or a variety of cancers, U.S. government health re.... , "Red and processed meats have been associated...
... Panomics Inc., a,developer of innovative technol...gy (PQB)(TM), and the exclusive provider of Quanti...xpression measurement and profiling,announced toda...livan, a global consulting firm, presented the awa...
...oliday season is a time for,office parties, sweet ...,goodies with the cold winter weather, and Decembe...itness Operations VP at 24 Hour Fitness health,clu...http://media.medialink.com/WebNR.aspx?story=34206 ...
...c. 10 Cardica, Inc.,(Nasdaq: CRDC ) today announ...ion granted to the underwriters of Cardica,s Novem...iters exercised their option to purchase,481,170 s... the offering. Allen & Company LLC, Needham & Comp...
Other Medicine News:Health News:Local School Wins National got milk?(R) Healthiest Student Bodies Contest 2Health News:Local School Wins National got milk?(R) Healthiest Student Bodies Contest 3Health News:Amedica Receives FDA Special 510(k) Clearance for its Valeo(TM) Ceramic Spinal Implant 2Health News:High Meat Consumption Linked to Heightened Cancer Risk 2Health News:High Meat Consumption Linked to Heightened Cancer Risk 3Health News:High Meat Consumption Linked to Heightened Cancer Risk 4Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 2Health News:Panomics Inc.: Recipient of the Frost & Sullivan 2007 United States Drug Discovery Technologies Entrepreneurial Company of the Year Award 3Health News:Cardica Announces Exercise of Over-Allotment Option 2Health News:Cardica Announces Exercise of Over-Allotment Option 3
Fogarty Arterial Embolectomy Catheter
AVX Catheter
QWIKCABLE Autoclavable Extension Cable
...ulse generators are meeting the clinical needs of ...ogists and anesthesiologists. And, they are of the...,Effective pacing with the adjustment of dials. .... Both the dual- and single-chamber temporary pac...
Medicine Products: